Federal contract award
W911QY21C0093
STABILITY TESTING
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Defense |
| Office | W6QK ACC-APG |
| NAICS | 541715 — Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) |
| PSC | AC13 — NATIONAL DEFENSE R&D SERVICES; DEPARTMENT OF DEFENSE - MILITARY; EXPERIMENTAL DEVELOPMENT |
| Parent award / vehicle | Not reported |
| Set-aside | NO SET ASIDE USED. |
| Pricing type | FIRM FIXED PRICE |
| Obligations | $17.4M |
| Current contract value | $17.4M |
| Potential contract value / ceiling | $29.1M |
| Start date | Aug 6, 2021 |
| Current end date | Aug 15, 2026 |
| Potential end date | Dec 15, 2027 |
| Latest award activity | May 13, 2026 |
| Source loaded | Sep 19, 2026 |
Funding and modification history
Showing the latest 28 of 28 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| May 13, 2026 | P00027 | $0 | STABILITY TESTING |
| Dec 4, 2025 | P00026 | $62.7K | STABILITY TESTING |
| Nov 18, 2025 | P00025 | $264.4K | STABILITY TESTING |
| Jul 30, 2025 | P00024 | $1.8M | PERFORMANCE OF STABILITY TESTING ON RF1V DRUG PRODUCT (DP). |
| Apr 23, 2025 | P00023 | $533.2K | PERFORMANCE OF STABILITY TESTING ON RF1V DRUG PRODUCT (DP). |
| Apr 9, 2025 | P00022 | $0 | PERFORMANCE OF STABILITY TESTING ON RF1V DRUG PRODUCT (DP). |
| Jan 28, 2025 | P00021 | $372.3K | PERFORMANCE OF STABILITY TESTING ON RF1V DRUG PRODUCT (DP). |
| Nov 14, 2024 | P00020 | $264.4K | PERFORMANCE OF STABILITY TESTING ON RF1V DRUG PRODUCT (DP). |
| Oct 10, 2024 | P00019 | $0 | PERFORMANCE OF STABILITY TESTING ON RF1V DRUG PRODUCT (DP). |
| Jul 30, 2024 | P00018 | $0 | PERFORMANCE OF STABILITY TESTING ON RF1V DRUG PRODUCT (DP). |
| Jul 22, 2024 | P00017 | $1.7M | PERFORMANCE OF STABILITY TESTING ON RF1V DRUG PRODUCT (DP). |
| May 31, 2024 | P00016 | $857.9K | PERFORMANCE STABILITY TESTING ON RF1V DRUG PRODUCT (DP). |
| Feb 9, 2024 | P00015 | $0 | PERFORMANCE OF STABILITY TESTING ON RF1V DRUG PRODUCT (DP). |
| Jan 4, 2024 | P00014 | $0 | ADMINISTRATIVE MODIFICATION TO REVISE SLIN DESCRIPTION. |
| Dec 21, 2023 | P00013 | $1.1M | EXERCISE OPTION SUBLINE ITEMS CDRL A002 AND A004 - MONTHLY REPORT (OPTION 3) |
| Jun 1, 2023 | P00012 | $2.1M | EXERCISE OPTION PERIOD 3 FOR CONTINUED STABILITY TESTING OF BOT AND PLG DP |
| Feb 24, 2023 | P00011 | $0 | TRANSFER CONTRACT ADMINISTRATION FROM ARMY CONTRACTING COMMAND-ABERDEEN PROVING GROUND, NATICK (ACC-APG, NATICK) DODAAC W911QY TO ACC-APG, EDGEWOOD, DODAAC W911SR. |
| Nov 15, 2022 | P00010 | $0 | EXTEND THE DELIVERY DATES AT NO ADDITIONAL COST FOR VARIOUS STABILITY TIMEPOINTS. |
| Aug 22, 2022 | P00009 | $123.6K | ADD SLIN 0041AA FOR ALIQUOTING OF BULK DRUG SUBSTANCE MATERIAL, EXERCISE OPTION SLIN 0005AB FOR CONTINUED STABILITY TESTING, AND EXTEND THE DELIVERY DATES FOR SLINS 0009, 0023, 0028 AND 0029 TO 31 AUGUST 2022, AT NO ADDITIONAL PRICE INCREASE. |
| May 31, 2022 | P00008 | $3.2M | EXERCISE OPTIONAL PERIOD 2 CLINS FOR CONTINUED STABILITY TESTING. |
| May 19, 2022 | P00007 | $0 | VACCINE STABILITY TESTING |
| Apr 15, 2022 | P00006 | $0 | VACCINE STABILITY TESTING |
| Mar 31, 2022 | P00005 | $0 | VACCINE STABILITY TESTING |
| Feb 22, 2022 | P00004 | $0 | EXTEND DELIVERY DATES AT NO ADDITIONAL COST TO THE GOVERNMENT FOR ONGOING STABILITY TESTING |
| Jan 25, 2022 | P00003 | $451.0K | EXERCISE OPTIONAL SLINS/TIMEPOINTS |
| Jan 18, 2022 | P00002 | $558.5K | OPTIONAL VIRUS STABILITY TESTING TIME POINTS |
| Dec 3, 2021 | P00001 | $1.6M | OPTIONAL STABILITY TESTING TIME POINTS |
| Aug 6, 2021 | 0 | $2.4M | STABILITY TESTING |
Estimated positioning window
Dec 15, 2026 – Jun 15, 2027
Recompete signal: . Rule-based research score; positioning dates are estimates.
70/100
Why this recompete signal
Contract timing and recorded acquisition signals at the time of calculation.
Stored score: 70/100. Available recorded signals: 65 points.
- Contract end 2027-12-15 (409 days from calculation)
- +25 points
- 6 historical awards in this buyer and category group
- +15 points
- 28 recorded award transactions
- +10 points
- Latest award action: 2026-05-13
- +5 points
- Parent award identifier recorded
- +0 points
- Solicitation identifier recorded
- +10 points
- Linked official forecast
- +0 points
- Calculated on
- 2026-11-01 10:17:53.997580+00:00
The historical group combines buyer, NAICS, and PSC. Multiple awards in this group do not by themselves establish repeated competitions.
Rule-based research score; it does not measure your chance of winning.
This older calculation does not retain a complete reproducible breakdown. Missing or changed inputs are not assigned invented points: Original award-value bonus input.
Recompete score calculated Nov 1, 2026.
Research next steps
- Check the linked forecast or SAM for a confirmed solicitation and current timing.
- Verify whether remaining options may extend performance beyond the current end date.
- Check the stated set-aside against the solicitation and current certifications.
- Review the award scope and buyer evidence before making a bid/no-bid decision.